DEF 14A: Encompass Health Sets Date for 2024 Annual Stockholders Meeting, Outlines Key Proposals

Encompass Health's proxy statement details proposals for the 2024 annual meeting, including director elections, auditor ratification, executive compensation, and a diversity, equity, and inclusion report request.

Summary

• Encompass Health Corporation will hold its 2024 Annual Meeting of Stockholders on May 2, 2024, at its corporate headquarters in Birmingham, Alabama.
• Stockholders of record as of March 8, 2024, are entitled to vote on several key proposals.
• The proposals include the election of 10 directors, ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm, an advisory vote on executive compensation, and a stockholder proposal requesting a report on the effectiveness of the company's diversity, equity, and inclusion efforts.
• The board of directors recommends voting FOR the election of each director nominee, FOR the ratification of the accounting firm appointment, FOR the approval of executive compensation, and AGAINST the stockholder proposal on diversity, equity, and inclusion.
• The proxy statement provides detailed information on corporate governance, board structure, executive compensation, and related matters.
• The board size will be reduced from 12 to 10 members following the retirement of two directors.
• The average tenure of the director nominees is approximately 5.5 years.
• The company's executive compensation program is designed to align management's interests with those of long-term stockholders, with a significant portion of compensation tied to performance metrics.
• The company has a compensation recoupment policy that applies to all officers and covers misconduct in certain cases.
• The company's CEO pay ratio is 211:1, with the median employee's 2023 total compensation being $41,969.
• The company prohibits executive officers and directors from hedging or pledging company securities.

Sentiment

Score: 7

Explanation: The document presents a balanced view of Encompass Health, highlighting both positive performance and areas for improvement. The board's recommendations and the company's commitment to corporate governance and executive compensation best practices contribute to a moderately positive sentiment.

Positives

• The company has a strong track record of say-on-pay approval, with a vote of greater than 93% every year.
• The company has strong corporate governance practices, including an independent board chairman, a majority of independent directors, and fully independent board committees.
• The company has a robust stock ownership requirement for directors and officers.
• The company has a declassified board with annual elections.
• The company has a focus on board diversity in succession planning.
• The company has an active stockholder engagement program.
• The company has regular reviews of succession plans for CEO and other senior executives.
• The company has ESG oversight by the full board and designated committees.
• The company has ESG/Sustainability targets in the executive compensation program.
• The company has an organizational focus on a strong culture that values diversity, equity, and inclusion and employee development and engagement.

Negatives

• The company's CEO pay ratio is 211:1, which may be viewed negatively by some stakeholders.
• The board recommends voting AGAINST the stockholder proposal on diversity, equity, and inclusion, which may be viewed negatively by some stakeholders.

Risks

• Healthcare is a highly regulated industry, and the company must adapt to changes in the regulatory and operating environments.
• The company faces risks related to recruitment, retention, inclusion and diversity, employee engagement, and employment litigation.
• The company faces cyber risks and must have a program designed to monitor, mitigate and respond to cyber risks, threats, and incidents.
• Noncompliance with financial covenants under the credit agreement could result in lenders requiring immediate repayment of all amounts borrowed.

Future Outlook

The company's executive compensation program is designed to incentivize and reward our NEOs and others for annual performance as measured against predetermined corporate quantitative objectives intended to improve the Company’s performance and promote stockholder value.

Management Comments

• On behalf of the directors, management and employees of Encompass Health, thank you for your continued support of and ownership in our company, stated Donald L. Correll, Chairman of the Board of Directors.

Industry Context

The document provides insights into Encompass Health's governance and compensation practices, which are benchmarked against a peer group of healthcare companies. The company's focus on quality of care and employee retention aligns with industry trends emphasizing value-based healthcare and workforce sustainability.

Comparison to Industry Standards

• The company benchmarks its executive compensation against a peer group of healthcare companies, including Acadia Healthcare, Chemed, Community Health Systems, DaVita, Select Medical Holdings, and Surgery Partners.
• The company's corporate governance practices, such as having an independent board chairman and fully independent board committees, are consistent with best practices for publicly traded companies.
• The company's ESG oversight and sustainability targets in the executive compensation program reflect a growing trend among healthcare providers to address environmental and social issues.

Stakeholder Impact

• The proposals outlined in the proxy statement will impact stockholders, employees, and other stakeholders.
• The election of directors will determine the leadership and oversight of the company.
• The ratification of the independent auditor will ensure the integrity of the company's financial reporting.
• The advisory vote on executive compensation will provide stockholders with an opportunity to express their views on the company's pay practices.
• The stockholder proposal on diversity, equity, and inclusion will address important social issues.

Next Steps

• Stockholders are encouraged to vote on the proposals outlined in the proxy statement.
• The board of directors will consider the results of the advisory vote on executive compensation.
• The company will continue to monitor and evaluate its corporate governance and compensation practices.
• The company will continue to engage with stockholders on key issues.

Key Dates

Keywords

proxy statement, executive compensation, board of directors, annual meeting, corporate governance, director election, audit committee, diversity, equity, inclusion, PricewaterhouseCoopers, stockholders